Our Proteomics Laboratory combines advanced instrumentation, high-throughput robotics, and an integrated data management system to provide automated and streamlined solutions for protein biomarker identification and analysis.
By evaluating proteomic changes, we identify and target disease-related biomarkers for disease detection and monitoring as well as potential new drug targets for therapeutic development. Proteomics methods for targeted quantitation or discovery-based proteomics are provided through mass spectrometry-based techniques. Using a selection of mass spectrometers available in our lab, intact masses of large proteins, dimers, trimers, and polymer samples are determined. Our Proteomics Mass Spectrometry facility leverages automation, rapid separation systems, and a diverse set of sensitive mass spectrometry instruments to detect, identify, and characterize proteins from purified samples or complex protein mixtures.